Search
for
Sort by
Research 61–90 of 337
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Hypersensitivity Reactions to Anticoagulant Drugs
- Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- Dermatological manifestations and associated factors in patients with Graves\' disease in Dakar
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Dermatological adverse events with taxane chemotherapy
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Patients with specific skin disorders who are affected by COVID ‐19: What do experiences say about management strategies? A systematic review
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- How Coronavirus Disease 2019 Changed Dermatology Practice in 1 Year Around the World
- Immune-Mediated Skin Reactions Induced by Recombinant Antibodies and Other TNF-Alpha Inhibitors
- Skin
- Dermatological Drugs, Topical Agents, and Cosmetics
- Tinea Capitis Kerion Type: A Case Report
- Clin-Alert
- Cutaneous manifestations of COVID-19 and vaccines for its prevention: a review of the existing literature
- Cutaneous manifestations of systemic infection in children
- Alopecia and Amphetamine Use-Reply
- The Assessment and Treatment of Geezers
- The Assessment and Treatment of Geezers
- Graft-versus-host disease
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Abemaciclib-Associated Skin, Hair, and Nail Toxicities: A Case Report
- A concomitant diagnosis of COVID‐19 infection and systemic lupus erythematosus complicated by a macrophage activation syndrome: A new case report
- A rash diagnosis